drugset / Trial / NCT00252863
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Symbicort dosed according to the Symbicort Maintenance and Reliever Therapy (SMART) concept is superior to standard asthma treatment according to the local German treatment guidelines.
Timeline
- Start
- 2004-12
- Primary completion
- —
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 200 ug | Inhaled |
| Subject | Budesonide/Formoterol | Unknown | — | Inhaled |
| Subject | Fluticasone | Other / unclassified | 250 ug | Inhaled |
| Subject | Fluticasone/Salmeterol | Unknown | — | Inhaled |
| Subject | Formoterol | Other / unclassified | 4.5 ug | Inhaled |
| Subject | Montelukast | Other / unclassified | 10 mg | — |
| Subject | Salbutamol | Unknown | 100 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 50 ug | Inhaled |
| Subject | Terbutaline | Small molecule | 0.5 mg | Inhaled |
| Subject | Theophylline | Small molecule | 200 mg | — |
| Subject | Theophylline | Small molecule | 300 mg | — |